Varsetatug (CX-2051 antibody) is a humanized IgG1kappa monoclonal antibody inhibitor targeting EpCAM/TROP1/CD326. Varsetatug serves as the antibody component of the ADC compound CX-2051. It can be used in research on cancers including breast cancer, prostate cancer and ovarian cancer[1][2].
Molecular Weight:
(155.116 kDa)
Purity:
97
CAS Number:
[3036004-28-8]
Target:
ADC Antibody,Transmembrane Glycoprotein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted